Related Experiment Video
Updated: Sep 13, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Impact of Individual Colonic Segment Histological Activity on Disease Relapse in Patients with Ulcerative Colitis
Steven Li Fraine1, Victoria Marcus2, Chelsea Maedler Kron2
1Inflammatory Bowel Disease Centre, Division of Gastroenterology and Hepatology, McGill University Health Centre (MUHC), Montreal, QC H4A-3J1, Canada.
None:
Background/Objectives: The aim of this study was to assess the role of histological activity in individual segments of the colon in predicting disease relapse in patients with ulcerative colitis. Methods: This was a prospective observational study on patients with ulcerative colitis in clinical remission. Biopsies were taken of multiple segments of the colon, and histological activity was assessed using the Geboes (GB) score. Patients were monitored for disease relapse for 12 months. The primary objective was to determine the predictive value of histological activity of the individual segments of the colon on disease relapse. The secondary objective was to assess whether having multiple segments in histological remission is associated with disease relapse. Results: Of 253 patients, 19% had disease relapse. Histological activity (GB ≥ 3.1) was not predictive of disease relapse for the rectum (adjusted odds ratio [aOR] 0.95, confidence interval [CI] 0.46-1.98, p = 0.894), sigmoid (aOR 0.67, CI 0.24-1.90, p = 0.451), descending colon (aOR 1.52, CI 0.43-5.39, p = 0.519), transverse colon (aOR 0.47, CI 0.10-2.18, p = 0.332), and right colon (aOR 1.75 CI 0.73-4.18, p = 0.209). Histological remission (GB ≤ 2.0) was also not predictive of remaining in remission for any individual colonic segment nor was there any benefit of having multiple segments with histological remission compared to having ≤1 segment in histological remission (aOR 0.56, CI 0.28-1.10, p = 0.093). Conclusions: Histological activity in any individual colonic segment or the number of colonic segments with histological remission was not predictive of disease relapse.
More Related Videos
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
08:52Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes
Published on: February 5, 2021
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...